HC Wainwright & Co. Reiterates Buy on PolyPid, Maintains $13 Price Target
Benzinga Newsdesk 4 hours ago
Analyst RatingsNewsReiterationPrice Target
HC Wainwright & Co. analyst Brandon Folkes reiterates PolyPid (NASDAQ:PYPD) with a Buy and maintains $13 price target.
HC Wainwright & Co. analyst Brandon Folkes reiterates PolyPid (NASDAQ:PYPD) with a Buy and maintains $13 price target.